Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Vectoris Pharma

M&A STATUS
M&A LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Developer of pharmaceuticals products. The company develops needle-free, non-inhaled insulin delivery technology which involves suspension of macro-molecular drugs, such as insulin to facilitate systemic delivery via the buccal membrane.

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Drug Delivery
Acquirer
PharmaDerm
Primary Office
  • United States

Vectoris Pharma Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Vectoris Pharma‘s full profile, request access.

Request full access to PitchBook